{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:50:37Z","timestamp":1786373437391,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"crossref","award":["I01HX002680"],"award-info":[{"award-number":["I01HX002680"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"VA Memphis and Long Beach Medical Centers"},{"name":"VA Information Resource Center","award":["Project No. SDR 02-237 and 98-004"],"award-info":[{"award-number":["Project No. SDR 02-237 and 98-004"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,10]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Lubiprostone has been suggested to exert kidney protective effects by improving the gut microbiome in animal studies.<\/jats:p>\n <\/jats:list-item>\n \n This comparative effectiveness study examined the association of lubiprostone (versus softeners) use with kidney outcomes in patients with CKD.<\/jats:p>\n <\/jats:list-item>\n \n Lubiprostone (versus softeners) use was associated with a lower risk of progressive kidney function decline in patients with CKD and constipation.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Lubiprostone, a chloride channel activator used to treat constipation, has been suggested to exert kidney protective effects by improving the gut microbiome. However, little is known about the comparative effectiveness of lubiprostone versus conventional laxatives on the risk of kidney outcomes in patients with CKD.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Among US veterans with CKD and constipation receiving care from the Veterans Administration health care system over 2004\u20132019, we identified incident users of lubiprostone versus stool softeners (docusate sodium or calcium), excluding combined users of the examined drugs. We used a target trial emulation approach to examine the association of lubiprostone versus stool softener use with a subsequent risk of a composite kidney outcome (incident ESKD, incident eGFR <15 ml\/min per 1.73 m\n 2<\/jats:sup>\n , or 57% reduction in eGFR, as primary) and change in eGFR (as secondary). The associations were examined using weighted Cox models for the composite kidney outcome and weighted multinomial logistic regression models for change in eGFR, applying a propensity score-overlap weighting method to minimize confounding by indication.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 52,231 patients who met eligibility criteria, 551 (1%) and 51,680 (99%) were incident users of lubiprostone and stool softeners, respectively. Compared with incident stool softener users, incident lubiprostone users had a significantly lower risk of a composite kidney outcome (hazard ratio [95% confidence interval], 0.70 [0.51 to 0.97]) and lower risk of experiencing more progressive eGFR decline (multinomial odds ratios [95% confidence interval] for eGFR slope <\u22123 and \u22123 to <\u22121 [versus \u22121 to <0] ml\/min per 1.73 m\n 2<\/jats:sup>\n per year, 0.39 [0.23 to 0.68] and 0.73 [0.53 to 1.01], respectively).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Incident lubiprostone (versus stool softener) use was independently associated with a lower risk of progressive kidney function decline in patients with CKD and constipation. Further studies are needed to refine the comparative effectiveness of different laxative types on kidney outcomes in clinical trials.<\/jats:p>\n <\/jats:sec>\n \n Podcast<\/jats:title>\n This article contains a podcast at https:\/\/dts.podtrac.com\/redirect.mp3\/www.asn-online.org\/media\/podcast\/CJASN\/2025_10_28_CJASNOctober.20.10..mp3<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.0000000779","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:02:27Z","timestamp":1751371347000},"page":"1341-1351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD"],"prefix":"10.2215","volume":"20","author":[{"given":"Keiichi","family":"Sumida","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamini","family":"Mallisetty","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-4069","authenticated-orcid":false,"given":"Prabin","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0080-4673","authenticated-orcid":false,"given":"Andrew","family":"Vo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida Nusrat","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-4870","authenticated-orcid":false,"given":"Fridtjof","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Preventive Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-0725","authenticated-orcid":false,"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension, and Transplantation, Department of Medicine, Harbor-UCLA and The Lundquist Institute, Torrance California"},{"name":"Tibor Rubin Veterans Affairs Medical Center, Long Beach, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-911X","authenticated-orcid":false,"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"},{"name":"Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"2","key":"B1-20260520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ekir.2019.11.002","article-title":"Constipation in CKD","volume":"5","author":"Sumida","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"1","key":"B2-20260520","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1038\/s41598-017-10663-w","article-title":"Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses","volume":"7","author":"Mancabelli","year":"2017","journal-title":"Sci Rep."},{"issue":"9","key":"B3-20260520","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s10620-011-1639-5","article-title":"Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey","volume":"56","author":"Sun","year":"2011","journal-title":"Dig Dis Sci."},{"issue":"8","key":"B4-20260520","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3111\/13696998.2014.919926","article-title":"The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population","volume":"17","author":"Guerin","year":"2014","journal-title":"J Med Econ."},{"issue":"4","key":"B5-20260520","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2016060656","article-title":"Constipation and incident CKD","volume":"28","author":"Sumida","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B6-20260520","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2018.12.021","article-title":"Constipation and risk of death and cardiovascular events","volume":"281","author":"Sumida","year":"2019","journal-title":"Atherosclerosis."},{"key":"B7-20260520","first-page":"5560310","article-title":"Roles of gut microbiota and metabolites in pathogenesis of functional constipation","volume":"2021","author":"Wang","year":"2021","journal-title":"Evid Based Complement Alternat Med."},{"issue":"11","key":"B8-20260520","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/gfaa205","article-title":"Laxative use in patients with advanced chronic kidney disease transitioning to dialysis","volume":"36","author":"Sumida","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B9-20260520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.jrn.2019.02.004","article-title":"Bowel habits and the association with uremic toxins in non-dialysis-dependent chronic kidney disease patients","volume":"30","author":"Ramos","year":"2020","journal-title":"J Ren Nutr."},{"issue":"3","key":"B10-20260520","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1556\/2060.106.2019.19","article-title":"The gut-kidney-heart axis in chronic kidney disease","volume":"106","author":"Sumida","year":"2019","journal-title":"Physiol Int."},{"issue":"4","key":"B11-20260520","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1681\/ASN.2020081120","article-title":"Laxative use and risk of dyskalemia in patients with advanced CKD transitioning to dialysis","volume":"32","author":"Sumida","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B12-20260520","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MNH.0000000000000661","article-title":"Microbiome modulation as a novel therapeutic approach in chronic kidney disease","volume":"30","author":"Sumida","year":"2021","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"1","key":"B13-20260520","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MNH.0000000000000753","article-title":"Novel intestinal dialysis interventions and microbiome modulation to control uremia","volume":"31","author":"Sumida","year":"2022","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"6s","key":"B14-20260520","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1053\/j.jrn.2022.12.003","article-title":"New insights into dietary approaches to potassium management in chronic kidney disease","volume":"33","author":"Sumida","year":"2023","journal-title":"J Ren Nutr."},{"issue":"2","key":"B15-20260520","doi-asserted-by":"crossref","first-page":"151408","DOI":"10.1016\/j.semnephrol.2023.151408","article-title":"Gut microbiota-targeted interventions in the management of chronic kidney disease","volume":"43","author":"Sumida","year":"2023","journal-title":"Semin Nephrol."},{"issue":"8","key":"B16-20260520","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1681\/ASN.2014060530","article-title":"Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD","volume":"26","author":"Mishima","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B17-20260520","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/ndt\/gfz126","article-title":"The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease","volume":"35","author":"Nanto-Hara","year":"2020","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"B18-20260520","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s10157-019-01727-4","article-title":"Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats","volume":"23","author":"Sueyoshi","year":"2019","journal-title":"Clin Exp Nephrol."},{"issue":"6","key":"B19-20260520","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00003495-200666060-00015","article-title":"Lubiprostone","volume":"66","author":"McKeage","year":"2006","journal-title":"Drugs."},{"issue":"6","key":"B21-20260520","doi-asserted-by":"crossref","first-page":"e2215878","DOI":"10.1001\/jamanetworkopen.2022.15878","article-title":"Association of uric acid-lowering therapy with incident chronic kidney disease","volume":"5","author":"Hassan","year":"2022","journal-title":"JAMA Netw Open."},{"issue":"4","key":"B22-20260520","doi-asserted-by":"crossref","first-page":"e246822","DOI":"10.1001\/jamanetworkopen.2024.6822","article-title":"Anti-tumor necrosis factor therapy and risk of kidney function decline and mortality in inflammatory bowel disease","volume":"7","author":"Sumida","year":"2024","journal-title":"JAMA Netw Open."},{"issue":"6","key":"B23-20260520","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.mayocp.2023.09.018","article-title":"Incident diuretic use and subsequent risk of bone fractures: a large nationwide observational study of US veterans","volume":"99","author":"Sumida","year":"2024","journal-title":"Mayo Clin Proc."},{"issue":"4","key":"B24-20260520","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/j.ajkd.2016.02.051","article-title":"Predialysis cardiovascular disease medication adherence and mortality after transition to dialysis","volume":"68","author":"Molnar","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B25-20260520","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.ajkd.2016.12.020","article-title":"Blood pressure before initiation of maintenance dialysis and subsequent mortality","volume":"70","author":"Sumida","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"19","key":"B28-20260520","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med."},{"issue":"3 suppl 1","key":"B29-20260520","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US renal data system 2018 annual data report: Epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis."},{"key":"B30-20260520","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the department of veterans affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"issue":"1","key":"B31-20260520","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol."},{"issue":"23","key":"B32-20260520","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA."},{"issue":"2","key":"B33-20260520","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2215\/CJN.0000000000000323","article-title":"Using restricted mean survival time to improve interpretability of time-to-event data analysis","volume":"19","author":"Charu","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"key":"B34-20260520","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.gloepi.2022.100080","article-title":"A practical guide to handling competing events in etiologic time-to-event studies","volume":"4","author":"Mansournia","year":"2022","journal-title":"Glob Epidemiol."},{"issue":"2","key":"B35-20260520","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CIA.S2938","article-title":"Lubiprostone: a novel treatment for chronic constipation","volume":"3","author":"Lacy","year":"2008","journal-title":"Clin Interv Aging."},{"issue":"Pt A","key":"B36-20260520","doi-asserted-by":"crossref","first-page":"121176","DOI":"10.1016\/j.lfs.2022.121176","article-title":"Lubiprostone significantly represses fatty liver diseases via induction of mucin and HDL release in mice","volume":"311","author":"Kim","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"B37-20260520","doi-asserted-by":"crossref","first-page":"e0218096","DOI":"10.1371\/journal.pone.0218096","article-title":"Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"14","author":"Arakawa","year":"2019","journal-title":"PLoS One."},{"issue":"39","key":"B38-20260520","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.3748\/wjg.14.6012","article-title":"Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine","volume":"14","author":"Moeser","year":"2008","journal-title":"World J Gastroenterol."},{"issue":"1","key":"B39-20260520","doi-asserted-by":"crossref","first-page":"C178","DOI":"10.1152\/ajpcell.00072.2011","article-title":"Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin","volume":"302","author":"Nighot","year":"2012","journal-title":"Am J Physiol Cell Physiol."},{"issue":"11","key":"B40-20260520","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S2468-1253(20)30216-8","article-title":"Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"5","author":"Kessoku","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"22","key":"B41-20260520","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2169\/internalmedicine.3158-19","article-title":"Effect of lubiprostone on urinary protein excretion: a report of two IgA nephropathy patients with chronic constipation","volume":"58","author":"Takeshita","year":"2019","journal-title":"Intern Med."},{"issue":"3","key":"B42-20260520","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10620-012-2509-5","article-title":"Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota","volume":"58","author":"Musch","year":"2013","journal-title":"Dig Dis Sci."},{"issue":"1","key":"B43-20260520","doi-asserted-by":"crossref","first-page":"lxac014","DOI":"10.1093\/jambio\/lxac014","article-title":"The critical role of gut microbiota dysbiosis in skeletal muscle wasting: a systematic review","volume":"134","author":"Nikkhah","year":"2023","journal-title":"J Appl Microbiol."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:52Z","timestamp":1786369552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000779","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2025-01-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}